BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 9190908)

  • 21. Self-thyroid epithelial cell (TEC)-reactive CD8+ T cell lines/clones derived from autoimmune thyroiditis lesions. They recognize self-thyroid antigens directly on TEC to exhibit T helper cell 1-type lymphokine production and cytotoxicity against TEC.
    Sugihara S; Fujiwara H; Niimi H; Shearer GM
    J Immunol; 1995 Aug; 155(3):1619-28. PubMed ID: 7543527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigen specific and MHC nonrestricted cytotoxicity of T cell receptor alpha beta+ and gamma delta+ human T cell clones isolated in IL-4.
    Paliard X; Yssel H; Blanchard D; Waitz JA; deVries JE; Spits H
    J Immunol; 1989 Jul; 143(2):452-7. PubMed ID: 2472439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor regression after adoptive transfer of effector T cells is independent of perforin or Fas ligand (APO-1L/CD95L).
    Winter H; Hu HM; Urba WJ; Fox BA
    J Immunol; 1999 Oct; 163(8):4462-72. PubMed ID: 10510388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The regulation of CD95 ligand expression and function in CTL.
    Li JH; Rosen D; Ronen D; Behrens CK; Krammer PH; Clark WR; Berke G
    J Immunol; 1998 Oct; 161(8):3943-9. PubMed ID: 9780162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutting edge: RANTES regulates Fas ligand expression and killing by HIV-specific CD8 cytotoxic T cells.
    Hadida F; Vieillard V; Mollet L; Clark-Lewis I; Baggiolini M; Debré P
    J Immunol; 1999 Aug; 163(3):1105-9. PubMed ID: 10415001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptide modification or blocking of CD8, resulting in weak TCR signaling, can activate CTL for Fas- but not perforin-dependent cytotoxicity or cytokine production.
    Kessler B; Hudrisier D; Schroeter M; Tschopp J; Cerottini JC; Luescher IF
    J Immunol; 1998 Dec; 161(12):6939-46. PubMed ID: 9862728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two types of anti-TL (thymus leukemia) CTL clones with distinct target specificities: differences in cytotoxic mechanisms and accessory molecule requirements.
    Tsujimura K; Takahashi T; Iwase S; Matsudaira Y; Kaneko Y; Yagita H; Obata Y
    J Immunol; 1998 Jun; 160(11):5253-61. PubMed ID: 9605121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different expression of Fas and Fas ligand in tumor infiltrating and peripheral lymphocytes of patients with renal cell carcinomas.
    Elsässer-Beile U; Gierschner D; Welchner T; Wetterauer U
    Anticancer Res; 2003; 23(1A):433-7. PubMed ID: 12680244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells.
    Shimizu M; Fontana A; Takeda Y; Yagita H; Yoshimoto T; Matsuzawa A
    J Immunol; 1999 Jun; 162(12):7350-7. PubMed ID: 10358186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IFN-gamma regulates Fas ligand expression in human CD4+ T lymphocytes and controls their anti-mycobacterial cytotoxic functions.
    Boselli D; Losana G; Bernabei P; Bosisio D; Drysdale P; Kiessling R; Gaston JS; Lammas D; Casanova JL; Kumararatne DS; Novelli F
    Eur J Immunol; 2007 Aug; 37(8):2196-204. PubMed ID: 17595676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4+ T cell clones isolated from human renal cell carcinoma possess the functional characteristics of Th2 helper cells.
    Schoof DD; Terashima Y; Peoples GE; Goedegebuure PS; Andrews JV; Richie JP; Eberlein TJ
    Cell Immunol; 1993 Aug; 150(1):114-23. PubMed ID: 8102084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones.
    Tsutsui H; Nakanishi K; Matsui K; Higashino K; Okamura H; Miyazawa Y; Kaneda K
    J Immunol; 1996 Nov; 157(9):3967-73. PubMed ID: 8892629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased lymphocyte apoptosis in Fas ligand transgenic mice.
    Cheng J; Liu C; Yang P; Zhou T; Mountz JD
    J Immunol; 1997 Jul; 159(2):674-84. PubMed ID: 9218582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen.
    Ettinger R; Panka DJ; Wang JK; Stanger BZ; Ju ST; Marshak-Rothstein A
    J Immunol; 1995 May; 154(9):4302-8. PubMed ID: 7536768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activated alpha beta-CD8+, but not alpha alpha-CD8+, TCR-alpha beta+ murine intestinal intraepithelial lymphocytes can mediate perforin-based cytotoxicity, whereas both subsets are active in Fas-based cytotoxicity.
    Gelfanov V; Gelfanova V; Lai YG; Liao NS
    J Immunol; 1996 Jan; 156(1):35-41. PubMed ID: 8598484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD30-regulated apoptosis in murine CD8 T cells after cessation of TCR signals.
    Telford WG; Nam SY; Podack ER; Miller RA
    Cell Immunol; 1997 Dec; 182(2):125-36. PubMed ID: 9514701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fas-independent cytotoxicity mediated by human CD4+ CTL directed against herpes simplex virus-infected cells.
    Yasukawa M; Ohminami H; Yakushijin Y; Arai J; Hasegawa A; Ishida Y; Fujita S
    J Immunol; 1999 May; 162(10):6100-6. PubMed ID: 10229852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneity in direct cytotoxic function of L3T4 T cells. TH1 clones express higher cytotoxic activity to antigen-presenting cells than TH2 clones.
    Chang JC; Zhang L; Edgerton TL; Kaplan AM
    J Immunol; 1990 Jul; 145(2):409-16. PubMed ID: 1973181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human autoreactive CD4+ T cell clones use perforin- or Fas/Fas ligand-mediated pathways for target cell lysis.
    Vergelli M; Hemmer B; Muraro PA; Tranquill L; Biddison WE; Sarin A; McFarland HF; Martin R
    J Immunol; 1997 Mar; 158(6):2756-61. PubMed ID: 9058810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leukocyte function-associated antigen-1-dependent lysis of Fas+ (CD95+/Apo-1+) innocent bystanders by antigen-specific CD8+ CTL.
    Kojima H; Eshima K; Takayama H; Sitkovsky MV
    J Immunol; 1997 Sep; 159(6):2728-34. PubMed ID: 9300693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.